Ascend FDA Wednesday, November 25, 2009 0.00 Neutral

FDA Approves METHADONE HYDROCHLORIDE — Ascend Laboratories, LLC

Ascend Laboratories, LLC secured FDA approval for its generic Methadone Hydrochloride product, a move expected to bolster the company's footprint in the opioid dependence treatment market. By establishing a low-cost alternative to existing branded products, Ascend is poised to gain market share and drive revenue growth.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day